DIAGNOS (OTCMKTS:DGNOF) Releases Earnings Results
by Teresa Graham · The Cerbat GemDIAGNOS (OTCMKTS:DGNOF – Get Free Report) announced its earnings results on Wednesday. The company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports. The company had revenue of $0.01 million during the quarter.
DIAGNOS Stock Up 2.0%
Shares of DGNOF opened at $0.20 on Friday. DIAGNOS has a twelve month low of $0.13 and a twelve month high of $0.29. The stock has a market capitalization of $24.54 million, a P/E ratio of -5.10 and a beta of -0.04. The company has a 50 day moving average of $0.23 and a 200-day moving average of $0.22.
About DIAGNOS
DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.
See Also
- Five stocks we like better than DIAGNOS
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse